7498 Results (Page 232 of 300)
Pharmaceuticals Markets Research Reports
UAE Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UAE Lung Cancer Therapeutics Market will reach a value of $299 Mn from $149 Mn in 2022, growing at a CAGR of 9.1% during 2022-2030. The Lung Cancer Therapeutics Market in UAE is dominated by a few domestic pharmaceutical companies such as Gulf Pharmaceutical Industries, Neopharma, and SITCO. The Lung Cancer Therapeutics Market in UAE is segmented into different types of cancer and different therapy type. Some of the major factors affecting the UAE lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
China Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the China liver cancer therapeutics market will reach a value of $953.6 Mn from $235.5 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. The liver cancer therapeutics market in China is dominated by a few domestic pharmaceutical companies such as BeiGene, Chi-Med, and Jiangsu HengRui Medicine. The liver cancer therapeutics market in China is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Brazil Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil liver cancer therapeutics market will reach a value of $286.7 Mn from $73.25 Mn in 2022, growing at a CAGR of 18.6% during 2022-30. The liver cancer therapeutics market in Brazil is dominated by a few domestic pharmaceutical companies such as Eurofarma, Aché Laboratórios, and Libbs Farmacêutica. The liver cancer therapeutics market in Brazil is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Thailand Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Thailand Lung Cancer Therapeutics Market will reach a value of $68 Mn from $36 Mn in 2022, growing at a CAGR of 8.5% during 2022-2030. The Lung Cancer Therapeutics Market in Thailand is dominated by a few domestic pharmaceutical companies such as Siam Bioscience, Bangkok Labs, and Bio Net-Asia. The Lung Cancer Therapeutics Market in Thailand is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Thailand lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Australia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Australia liver cancer therapeutics market will reach a value of $142.3 Mn from $35.2 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. Liver cancer therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Imugene Limited, Kazia Therapeutics, and Sirtex Medical Limited. Liver cancer therapeutics in Australia is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Spain Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Spain Lung Cancer Therapeutics Market will reach a value of $996 Mn from $575 Mn in 2022, growing at a CAGR of 7.1% during 2022-2030. The Lung Cancer Therapeutics Market in Spain is dominated by a few domestic pharmaceutical companies such as Grifols, PharmaMar, and Almirall. The Lung Cancer Therapeutics Market in Spain is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Spain lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
South Korea Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea Lung Cancer Therapeutics Market will reach a value of $875 Mn from $435 Mn in 2022, growing at a CAGR of 9.1% during 2022-2030. The Lung Cancer Therapeutics Market in South Korea is dominated by a few domestic pharmaceutical companies such as Yuhan Corporation, Hanmi Pharmaceutical, and Celltrion Healthcare. The Lung Cancer Therapeutics Market in South Korea is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South Korean lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
South Africa Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the South Africa Lung Cancer Therapeutics Market will reach a value of $396 Mn from $194 Mn in 2022, growing at a CAGR of 9.3% during 2022-2030. The Lung Cancer Therapeutics Market in South Africa is dominated by a few domestic pharmaceutical companies such as Akacia Medical, Adcock Ingram, and Aspen Pharmacare. The Lung Cancer Therapeutics Market in South Africa is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South African lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Singapore Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore Lung Cancer Therapeutics Market will reach a value of $70 Mn from $36 Mn in 2022, growing at a CAGR of 8.7% during 2022-2030. The Lung Cancer Therapeutics Market in Singapore is dominated by a few domestic pharmaceutical companies such as Roche Singapore, ASTAR Biomedical, and National Cancer Centre Singapore. The Lung Cancer Therapeutics Market in Singapore is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Singapore lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Saudi Arabia Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Saudi Arabia Lung Cancer Therapeutics Market will reach a value of $1056 Mn from $507 Mn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Lung Cancer Therapeutics Market in Saudi Arabia is dominated by a few domestic pharmaceutical companies such as Tabuk Pharmaceuticals, BioVet, and SPIMACO. The Lung Cancer Therapeutics Market in Saudi Arabia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Saudi Arabia lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Romania Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Romania Lung Cancer Therapeutics Market will reach a value of $164 Mn from $86 Mn in 2022, growing at a CAGR of 8.4% during 2022-2030. The Lung Cancer Therapeutics Market in Romania is dominated by a few domestic pharmaceutical companies such as Adamed Group, Polpharma Group, and Gedeon Richter Polska. The Lung Cancer Therapeutics Market in Romania is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Romania lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Poland Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Poland Lung Cancer Therapeutics Market will reach a value of $333 Mn from $173 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in Poland is dominated by a few domestic pharmaceutical companies such as Adamed Group, Polpharma Group, and Gedeon Richter Polska. The Lung Cancer Therapeutics Market in Poland is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Poland lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Philippines Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines Lung Cancer Therapeutics Market will reach a value of $127 Mn from $66 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in the Philippines is dominated by a few domestic pharmaceutical companies such as United Laboratories, Pfizer Philippines, and Roche Philippines. The Lung Cancer Therapeutics Market in the Philippines is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Philippines lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Netherlands Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Netherlands Lung Cancer Therapeutics Market will reach a value of $155 Mn from $77 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in the Netherlands is dominated by a few domestic pharmaceutical companies such as Cristal Therapeutics, ISA Pharmaceuticals, and Merus. The Lung Cancer Therapeutics Market in the Netherlands is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Netherlands lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Kenya Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Kenya Lung Cancer Therapeutics Market will reach a value of $396 Mn from $194 Mn in 2022, growing at a CAGR of 9.3% during 2022-2030. The Lung Cancer Therapeutics Market in Kenya is dominated by a few domestic pharmaceutical companies such as Universal Corporation Limited, Cosmos Limited, and Avenue Healthcare. The Lung Cancer Therapeutics Market in Kenya is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Kenya lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.l
Japan Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Japan Lung Cancer Therapeutics Market will reach a value of $3.5 Bn from $1.8 Bn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in Japan is dominated by a few domestic pharmaceutical companies such as Chugai Pharmaceutical, Taiho Pharmaceutical, and Ono Pharmaceutical. The Lung Cancer Therapeutics Market in Japan is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Japanese lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Italy Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Italy Lung Cancer Therapeutics Market will reach a value of $1286 Mn from $715 Mn in 2022, growing at a CAGR of 7.6% during 2022-2030. The Lung Cancer Therapeutics Market in Italy is dominated by a few domestic pharmaceutical companies such as Menarini, Chiesi, and MolMed. The Lung Cancer Therapeutics Market in Italy is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Italy lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Indonesia Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia Lung Cancer Therapeutics Market will reach a value of $334 Mn from $179 Mn in 2022, growing at a CAGR of 8.1% during 2022-2030. The Lung Cancer Therapeutics Market in Indonesia is dominated by a few domestic pharmaceutical companies such as Dexa Medica, Kalbe Farma, and Phapros. The Lung Cancer Therapeutics Market in Indonesia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Indonesia lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
India Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the India Lung Cancer Therapeutics Market will reach a value of $1259 Mn from $542 Mn in 2022, growing at a CAGR of 11.1% during 2022-2030. The Lung Cancer Therapeutics Market in India is dominated by a few domestic pharmaceutical companies such as Lupin, Cipla, and Biocon. The Lung Cancer Therapeutics Market in India is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Indian lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
France Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the France Lung Cancer Therapeutics Market will reach a value of $1420 Mn from $820 Mn in 2022, growing at a CAGR of 7.1% during 2022-2030. The Lung Cancer Therapeutics Market in France is dominated by a few domestic pharmaceutical companies such as Sanofi, Ipsen, and Innate Pharma. The Lung Cancer Therapeutics Market in France is segmented into different types of cancer and different therapy type. Some of the major factors affecting the France lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Egypt Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt Lung Cancer Therapeutics Market will reach a value of $174 Mn from $83 Mn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Lung Cancer Therapeutics Market in Egypt is dominated by a few domestic pharmaceutical companies such as EIPICO, Pharco Pharmaceuticals, and El-Nasr Pharmaceutical Chemicals. The Lung Cancer Therapeutics Market in Egypt is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Egypt lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
China Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the China Lung Cancer Therapeutics Market will reach a value of $5 Bn from $2.4 Bn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Lung Cancer Therapeutics Market in China is dominated by a few domestic pharmaceutical companies such as BeiGene, Jiangsu Hengrui Medicine, and Hutchison. The Lung Cancer Therapeutics Market in China is segmented into different types of cancer and different therapy type. Some of the major factors affecting the China lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Tanzania Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Tanzania liver disease therapeutics market will reach a value of $15 Mn from $9 Mn in 2022, growing at a CAGR of 6.6% during 2022-2030. The liver disease therapeutics in Tanzania is dominated by a few domestic pharmaceutical companies such as Africa Pharmaceutical Company, Dexa Medica, and Elys Chemical Industries. The liver disease therapeutics market in Tanzania is segmented into different types of disease and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Belgium Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Belgium Lung Cancer Therapeutics Market will reach a value of $122 Mn from $66 Mn in 2022, growing at a CAGR of 8.1% during 2022-2030. The Lung Cancer Therapeutics Market in Belgium is dominated by a few domestic pharmaceutical companies such as Ion Beam Applications, Oncurious, and Oxurion. The Lung Cancer Therapeutics Market in Belgium is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Belgium lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Poland Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Poland liver disease therapeutics market will reach a value of $216 Mn from $134 Mn in 2022, growing at a CAGR of 6.2 % during 2022-2030. The liver disease therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma, Adamed, and Hasco-Lek. The liver disease therapeutics market in Poland is segmented into different types of disease and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
